SU

260.65

+2.44%↑

BAS

54.93

+2.6%↑

REP

21.71

-5.32%↓

AM

326.8

-2.91%↓

EXE.US

98.98

-0.43%↓

SU

260.65

+2.44%↑

BAS

54.93

+2.6%↑

REP

21.71

-5.32%↓

AM

326.8

-2.91%↓

EXE.US

98.98

-0.43%↓

SU

260.65

+2.44%↑

BAS

54.93

+2.6%↑

REP

21.71

-5.32%↓

AM

326.8

-2.91%↓

EXE.US

98.98

-0.43%↓

SU

260.65

+2.44%↑

BAS

54.93

+2.6%↑

REP

21.71

-5.32%↓

AM

326.8

-2.91%↓

EXE.US

98.98

-0.43%↓

SU

260.65

+2.44%↑

BAS

54.93

+2.6%↑

REP

21.71

-5.32%↓

AM

326.8

-2.91%↓

EXE.US

98.98

-0.43%↓

Search

Eurofins Scientific SE

Geschlossen

63.92 0.6

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

63.9

Max

64.12

Schlüsselkennzahlen

By Trading Economics

Einkommen

105M

228M

Verkäufe

1.9B

3.7B

KGV

Branchendurchschnitt

26.235

77.167

Dividendenrendite

1.11

Gewinnspanne

6.2

Angestellte

65,694

EBITDA

285M

693M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+20.56% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.11%

3.29%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-764M

12B

Vorheriger Eröffnungskurs

63.32

Vorheriger Schlusskurs

63.92

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Eurofins Scientific SE Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Apr. 2026, 17:04 UTC

Wichtige Markttreiber

FDA Rejects Replimune's Melanoma Drug for a Second Time

11. Apr. 2026, 00:00 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Big Yachts, Big Bucks -- Barrons.com

10. Apr. 2026, 21:55 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10. Apr. 2026, 21:01 UTC

Ergebnisse

Cango Inc.: Files Annual Report on Form 20-F With SEC

10. Apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10. Apr. 2026, 20:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

10. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Apr. 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10. Apr. 2026, 20:10 UTC

Akquisitionen, Fusionen, Übernahmen

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10. Apr. 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10. Apr. 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10. Apr. 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Apr. 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10. Apr. 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10. Apr. 2026, 18:25 UTC

Market Talk
Wichtige Nachrichtenereignisse

Precious Metals Finish With Weekly Gains -- Market Talk

10. Apr. 2026, 18:05 UTC

Market Talk

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10. Apr. 2026, 17:31 UTC

Market Talk
Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10. Apr. 2026, 17:26 UTC

Ergebnisse

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10. Apr. 2026, 17:10 UTC

Market Talk

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10. Apr. 2026, 17:00 UTC

Wichtige Nachrichtenereignisse

Construction Business Taking a Hit From Iran Conflict -- WSJ

10. Apr. 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

10. Apr. 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10. Apr. 2026, 16:12 UTC

Ergebnisse

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10. Apr. 2026, 16:11 UTC

Ergebnisse

Partners Group: Traditional Programs Contributed $3.3B

10. Apr. 2026, 16:10 UTC

Ergebnisse

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10. Apr. 2026, 16:10 UTC

Ergebnisse

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10. Apr. 2026, 16:10 UTC

Ergebnisse

Partners Group 1Q New Client Demand $8.3B

10. Apr. 2026, 16:09 UTC

Ergebnisse

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10. Apr. 2026, 15:54 UTC

Akquisitionen, Fusionen, Übernahmen

Plenitude Completes Acquisition of Acea Energia

10. Apr. 2026, 15:38 UTC

Market Talk

Global Energy Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Eurofins Scientific SE Prognose

Kursziel

By TipRanks

20.56% Vorteil

12-Monats-Prognose

Durchschnitt 77.35 EUR  20.56%

Hoch 81 EUR

Tief 73.7 EUR

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Eurofins Scientific SE – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

1

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

54.22 / 56.82Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat